Roche’s flu drug Xofluza meets primary endpoint in phase III children study

Roche’s flu drug Xofluza meets primary endpoint in phase III children study

Submitted by admin on July 3, 2019 - 9:49am
Source: 
Pharmaceutical Business Review
News Tags: 
Roche
clinical trials
Xofluza
pediatric
influenza
Headline: 
Roche’s flu drug Xofluza meets primary endpoint in phase III children study
snippet: 

Roche’s flu drug Xofluza (baloxavir marboxil) has achieved primary endpoint in phase III Ministone-2 children study.

Do Not Allow Advertisers to Use My Personal information